Bruker Cellular Analysis Competitors and Similar CompaniesClear all
Bruker Cellular Analysis's competitors and similar companies include GenScript, Crescendo Biologics, Spark Therapeutics and AbCellera Biologics.
 Bruker Cellular Analysis Bruker Cellular Analysis (formerly known as Phenomex, Berkeley Lights) is a digital cell biology company focused on enabling the development of biotherapeutics and other cell-based products. |  GenScript Genscript Biotech is a biotech company focusing on early drug discovery and development services. |  Crescendo Biologics Crescendo Biologics is a provider of human VH antibody fragment therapeutics created to optimize antibodies and a transgenic mouse which produces heavy chain only antibodies. |  AbCellera Biologics AbCellera Biologics is a provider of an AI-powered drug discovery platform for antibody therapies. | ||
Founding Date | Founding Date 2011 | Founding Date 2002 | Founding Date 2007 | Founding Date 2013 | Founding Date 2012 |
Type | Type Subsidiary | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Emeryville, US HQ | Locations Nanjing, CN HQ Tokyo, JP Seoul, KR Rijswijk, NL Singapore, SG Oxford, GB Piscataway, US | Locations Babraham, GB HQ | Locations Philadelphia, US HQ | Locations Vancouver, CA HQ |
Employees | Employees 1391% decrease | Employees 5,568 | Employees 12 | Employees 36817% increase | Employees 596 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 4.4 b | Valuation ($) 833.9 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $78.6m (FY, 2022) | Revenue (est.) $959.5m (FY, 2025) | Revenue (est.) £7.5m (FY, 2018) | Revenue (est.) $64.7m (FY, 2018) | Revenue (est.) $75.1m (FY, 2025) |
Cost of goods | Cost of goods $24.8m (FY, 2022) | Cost of goods $332.3m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $53.8m (FY, 2022) | Gross profit $650.8m (FY, 2025) | Gross profit £7.5m (FY, 2018) | Gross profit N/A | Gross profit N/A |
Net income | Net income ($98m) (FY, 2022) | Net income ($532.4m) (FY, 2025) | Net income (£1.8m) (FY, 2018) | Net income ($78.8m) (FY, 2018) | Net income ($146.4m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 124.7m | Total funding raised N/A | Total funding raised $ 116.2m | Total funding raised $ 122.8m | Total funding raised $ 115m |
For sources of this data, please see the company profile
View Company Profiles
GenScript
HQ
Nanjing, CN
Employees
5,568
Genscript Biotech is a biotech company focusing on early drug discovery and development services.
View companyCrescendo Biologics
HQ
Babraham, GB
Employees
12
Crescendo Biologics is a provider of human VH antibody fragment therapeutics created to optimize antibodies and a transgenic mouse which produces heavy chain only antibodies.
View company
Spark Therapeutics
HQ
Philadelphia, US
Employees
368↑ 17% increase
Spark Therapeutics is a gene therapy company.
View companyAbCellera Biologics
HQ
Vancouver, CA
Employees
596
AbCellera Biologics is a provider of an AI-powered drug discovery platform for antibody therapies.
View company